Clinical gene therapy for arthritis

Drugs of Today

Volumn 35, Issue 4-5, 1999, Pages 389-396

  Ghivizzani, Steven C ^a   Muzzonigro, Thomas S ^a   Kang, Richard ^a   Evans, Christopher H ^a   Robbins, Paul D ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1 RECEPTOR BLOCKING AGENT;

ANIMAL EXPERIMENT; CONFERENCE PAPER; DRUG SAFETY; GENE THERAPY; INTRAARTICULAR DRUG ADMINISTRATION; NONHUMAN; RABBIT; RHEUMATOID ARTHRITIS; TREATMENT OUTCOME;

EID: 0032777810     PISSN: 16993993     EISSN: 16994019     Source Type: Journal    
DOI: 10.1358/dot.1999.35.4-5.552212     Document Type: Conference Paper

References (27)

1. Finck, B.K., Linsley, P.S., Wofsy, D. Treatment of murine lupus with CTLA4Ig. Science 1994, 265: 1225-7.
2. Datta, S.K., Kalled, S.L. CD40-CD40 ligand interaction in autoimmune disease. Arthritis Rheum 1997, 40: 1735-45.
3. Banda, M.J., Howard, E.W. Secreted inhibitors of mammalian metalloproteinases. Ann NY Acad Sci 1991, 624: 109-15.
4. Arend, W.P. Interleukin-1 receptor antagonist. Adv Immunol 1993, 54: 167-227.
5. Hardingham, T.E., Bayliss, M.T., Rayan, V., Noble, D.P. Effects of growth factors and cytokines on proteoglycan turnover in articular cartilage. BrJ Rheum 1994, 31 (Suppl. 1): 1-6.
6. Hunziker, E.B., Rosenberg, L. Induction of repair in partial thickness articular cartilage lesions by time release of TGF-β. Trans Orthop Res Soc 1994, 19: 236.
7. Hung, G.L., Evans, C.H. Synovium. In: F.H. Fu, C.D. Harner and K.G. Vince (Eds.). Knee Surgery, Vol. 1. Williams and Wilkins: Baltimore 1982, 141-54.
8. Dingle, J.T., Thomas, D.P., King, B., Bard, D.R. In vivo studies of articular tissue damage mediated by catabolin/interleukin-1. Ann Rheum Dis 1987, 46: 527-32.
9. Evans, C.H., Robbins, P.D. Gene therapy as a treatment for rheumatoid arthritis. Exp Opin Invest Drugs 1995, 4: 843-52.
10. Evans, C.H., Robbins, P.D. Pathways to gene therapy in rheumatoid arthritis. Curr Opin Rheum 1996, 8: 230-4.
11. Bandara, G., Mueller, G.M., Galea-Lauri, M. et al. Intraarticular expression of biologically active interleukin-1-receptor antagonist protein by ex vivo gene transfer. Proc Natl Acad Sci USA 1993, 90: 10764-8.
12. Roessler, B.J., Allen, E.D., Wilson, J.M., Hartman, J.W., Davidson, B.L. Adenoviral-mediated gene transfer to rabbit synovium in vivo. J Clin Invest 1993, 92: 1085-92.
13. Nita, I., Ghivizzani, S.C., Galea-Lauri, M. et al. Direct gene delivery to synovium: an evaluation of potential vectors in vitro and in vivo. Arthritis Rheum 1996, 39: 820-8
14. Pettipher, E.R., Higgs, G.A., Henderson, B. Interleukin-1 induces leukocyte infiltration and cartilage proteoglycan degradation in the synovial joint. Proc Natl Acad Sci USA 1986, 83: 8749-53.
15. Ghivizzani, S.C., Kang, R., Georgescu, H.I. et al. Constitutive intraarticular expression of human IL-1β following gene transfer to rabbit synovium produces all major pathologies of human arthritis. J Immunol 1997: 3604-12.
16. Wooley, P.H., Whalen, J.D., Chapman, D.L. et al. The effect of interleukin-1 receptor antagonist protein on type II collagen-induced arthritis and antigen-induced arthritis in mice. Arthritis Rheum 1993, 36: 1305-12.
17. Arner, E.C., Harris, R.R., Di Meo, R.C., Collins, R.C., Galbraith, W. Interleukin-1 receptor antagonist inhibits proteoglycan breakdown in antigen-induced but not polycation-induced arthritis in the rabbit. J Rheumatol 1995, 22: 1338-46.
18. Campion, G.V., Lebsack, M.E., Lookabaugh, J., Gorden, G., Catalano, M. Dose-range and dose-frequency of recombinant human interleukin-1 receptor antagonist in patients with rheumatoid arthritis. Arthritis Rheum 1996, 39: 1092-101.
19. Granowitz, E.V. et al. Pharmacokinetics, safety, and immunomodulatory effects of human recombinant interleukin-1 receptor antagonist in healthy humans. Cytokine 1992, 4: 353-60.
20. Van Zee, K.J., Coyle, S.M., Calvano, S.E. Influence of IL-1 receptor blockade on the human response to endotoxemia. J Immunol 1995, 154: 1499-1507.
21. Robbins, P.D., Tahara, H., Mueller, G.M. et al. Retroviral vectors for use in human gene therapy for cancer, Gaucher disease, and arthritis. Ann NY Acad Sci 1994, 716: 72-89.
22. Evans, C.H., Robbins, P.D., Ghivizzani, S.C. et al. Clinical trial to assess the safety, feasibility, and efficacy of transferring a potentially antiarthritic cytokine gene to human joints with rheumatoid arthritis. Hum Gene Ther 1996, 7: 1261-80.
23. Hung, G.L., Galea-Lauri, J., Mueller, G.M. et al. Suppression of intraarticular responses to interleukin-1 by transfer of the interleukin-1 receptor antagonist gene to synovium. Gene Ther 1993, 1: 64-9.
24. Otani, K., Nita, I., Macaulay, W., Georgescu, H.I., Robbins, P.D., Evans, C.H. Suppression of antigen-induced arthritis in rabbits by ex vivo gene therapy. J Immunol 1996, 156: 3558-62
25. Boggs, S.S., Patrene, K.D., Mueller, G.M., Evans, C.H., Doughty, L.A., Robbins, P.D. Prolonged systemic expression of human IL-1 receptor antagonist protein in sera of lethally irradiated mice reconstituted with hematopoietic stem cells transduced with a retrovirus containing the IL-1RA gene. Gene Ther 1995, 2: 632-8.
26. Glorioso, J.C., Krisky, D., Marconi, P. et al. Progress in development of herpes simplex virus gene vectors for treatment of rheumatoid arthritis. Adv Drug Deliv Rev 1997, 27: 41-57.
27. Ghivizzani, S.C., Lechman, E.R., Tio, C. et al. Direct retroviral mediated gene transfer to the synovium of the rabbit knee: Implications for arthritis gene therapy. Gene Ther 1997, 4: 977-82.